dsip peptide oral (5mg vials) Delta-Sleep Inducing Peptide - CPC

Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2

Some of the neurological functions that have been examined to determine whether BPC-157 is involved include: Peripheral nerve regeneration Models of central nervous system injury Neurovascular interactions Dopaminergic signaling Nitric oxide signaling Cellular stress signaling Experiments with animal subjects have shown promising results in certain experimental models

10.12998/wjcc.v3.i5.418 World J

While the results are promising, a lot of evidence is anecdotal or from animal studies